Trimethoprim-Sulfamethoxazole Plus Azithromycin to Prevent Malaria and Sexually Transmitted Infections in Pregnant Women With HIV (PREMISE): A Randomized, Double-Masked, Placebo-Controlled, Phase IIB Clinical Trial.
Jodie A DionneJudith Anchang-KimbiJiaying HaoDustin Marsh LongTobias ApinjohPius TihRahel MbahEdward Ndze NgahJonathan J JulianoMauricio KahnKatia BruxvoortBarbara Van Der PolAlan T N TitaJeanne MarrazzoEric AchidiPublished in: Open forum infectious diseases (2024)
The addition of monthly azithromycin to daily TMP-SMX prophylaxis in pregnant women living with HIV in Cameroon did not reduce the risk of malaria or bacterial STI at delivery.
Keyphrases
- pregnant women
- clinical trial
- plasmodium falciparum
- double blind
- placebo controlled
- men who have sex with men
- hiv positive
- hiv testing
- phase ii
- antiretroviral therapy
- hiv infected
- study protocol
- human immunodeficiency virus
- phase iii
- hepatitis c virus
- physical activity
- pregnancy outcomes
- open label
- squamous cell carcinoma
- antibiotic resistance genes
- randomized controlled trial
- south africa
- phase ii study
- radiation therapy
- wastewater treatment